Projects funded by the NCN
BET Bromodomain Inhibitors and improvement of glioblastoma therapy
2017/27/B/NZ5/02620
Keywords:
Bromodomain inhibitors nitric oxide glioblastoma photodynamic therapy
Descriptors:
- NZ5_7: Human disease treatment
- NZ1_2: Biochemistry
- NZ3_7: Signal transduction
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: OPUS 14 - announced on 2017-09-15
Amount awarded: 1 895 000 PLN
Project start date (Y-m-d): 2018-08-03
Project end date (Y-m-d): 2023-01-02
Project duration:: 53 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.